LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 5 of total 5

Search options

  1. Article ; Online: The Bioequivalence Study of Two Dexketoprofen 25 mg Film-Coated Tablet Formulations in Healthy Males Under Fasting Conditions.

    Yerlikaya, Fırat / Arslan, Aslıhan / Baş, Hilal / Sağlam, Onursal / Aytaç, Sevim Peri

    Turkish journal of pharmaceutical sciences

    2023  Volume 20, Issue 2, Page(s) 115–120

    Abstract: Objectives: Dexketoprofen is a non-steroidal analgesic/anti-inflammatory drug and its trometamol salt is extensively preferred in mild or moderate pain due to its rapid onset of relief. A new formulation of 36.9 mg of dexketoprofen trometamol ( ... ...

    Abstract Objectives: Dexketoprofen is a non-steroidal analgesic/anti-inflammatory drug and its trometamol salt is extensively preferred in mild or moderate pain due to its rapid onset of relief. A new formulation of 36.9 mg of dexketoprofen trometamol (equivalent to 25 mg dexketoprofen) tablet has been developed and its bioequivalence to the reference product was proven.
    Materials and methods: An open-label, single-dose, randomized, two-period, and cross-over bioequivalence study was conducted with healthy males under fasting conditions for two different tablet formulations of 25 mg dexketoprofen. To prove the bioequivalence of the test product with the reference product, a comparison study has been performed in compliance with regulations in force under Good Clinical Practice principles. A single-center clinical study was run and blood samples of the participants were withdrawn at specified time points, before and after dosing, to measure the plasma concentrations of dexketoprofen trometamol. A validated analytical method has been developed using an liquid chromatography with tandem mass spectrometry. Instrument to assess the plasma concentrations of the test and reference products.
    Results: Forty-seven volunteers completed clinical phase of the study. For the test and reference products, the mean ± standard deviations (SD) of C
    Conclusion: After statistical evaluation of the analytical results, the test and reference products were considered bioequivalent. Both products were well tolerated and considered as safe.
    Language English
    Publishing date 2023-05-09
    Publishing country Turkey
    Document type Journal Article
    ZDB-ID 2238484-4
    ISSN 2148-6247 ; 2148-6247
    ISSN (online) 2148-6247
    ISSN 2148-6247
    DOI 10.4274/tjps.galenos.2022.95994
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: A Study to Compare Bioequivalence Approach Between FDA and EMA in a Highly Variable Drug: Pinaverium Bromide Film Tablets.

    Arısoy, Mustafa / Saydam, Mehtap / Ekin Dolaksız, Yasemin / Talay, Çağrı / Sağlam, Onursal / Demiray, Gökçe / Doğan Kurtoğlu, Emel

    Journal of pharmaceutical sciences

    2022  Volume 111, Issue 11, Page(s) 3149–3154

    Abstract: The aim of this study is to investigate pharmacokinetic parameters of test and reference film tablet formulations of a highly variable drug, pinaverium bromide, under fasting conditions and to assess their bioequivalence in accordance with the FDA and ... ...

    Abstract The aim of this study is to investigate pharmacokinetic parameters of test and reference film tablet formulations of a highly variable drug, pinaverium bromide, under fasting conditions and to assess their bioequivalence in accordance with the FDA and EMA criteria. A randomised open-label, single oral dose, three-sequence, three-period, semi-replicated, cross-over trial was conducted with 36 healthy subjects. The intrasubject variability of reference products for C
    MeSH term(s) Area Under Curve ; Cross-Over Studies ; Healthy Volunteers ; Humans ; Morpholines ; Tablets ; Therapeutic Equivalency
    Chemical Substances Morpholines ; Tablets ; pinaverium (U2368VVE7O)
    Language English
    Publishing date 2022-08-15
    Publishing country United States
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 3151-3
    ISSN 1520-6017 ; 0022-3549
    ISSN (online) 1520-6017
    ISSN 0022-3549
    DOI 10.1016/j.xphs.2022.08.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Bioequivalence study of two favipiravir tablet formulations in healthy male subjects.

    Sağlam, Onursal / Güney, Berrak / Saraner, Nihal / Sevici, Gamze / Doğan-Kurtoğlu, Emel / Ulusoy, Merve G / Demiray, Gökçe / Nacak, Muradiye / Erenmemişoğlu, Aydın / Ozbek, Mahmut / Aytaç, Peri

    International journal of clinical pharmacology and therapeutics

    2021  Volume 59, Issue 5, Page(s) 409–416

    Abstract: Objective: The global pandemic called COVID-19 has dragged the world into a healthcare crisis, and favipiravir is one of the most prescribed agents against the virus so far. Favipiravir is a repurposed antiviral agent in treatment of SARS-CoV-2 ... ...

    Abstract Objective: The global pandemic called COVID-19 has dragged the world into a healthcare crisis, and favipiravir is one of the most prescribed agents against the virus so far. Favipiravir is a repurposed antiviral agent in treatment of SARS-CoV-2 infection, and to meet the current need, pharmaceutical companies are working for manufacturing licensed generic favipiravir. For getting the marketing authorization, the bioequivalence of the generic product must be proven first. The aim of this study is to demonstrate the bioequivalence of a new favipiravir tablet formulation as compared to the reference tablet formulation in healthy male subjects under fasting conditions.
    Materials and methods: To prove the bioequivalence, a randomized, single oral dose, cross-over, two-period study was carried out in 30 healthy subjects under fasting conditions. Plasma favipiravir levels were quantified by using an in-house-developed high performance liquid chromatography with mass spectrometry detector (LC-MSD) method.
    Results: The 90% CIs for the test/reference geometric mean ratios of the C
    Conclusion: This single-dose study has shown that the test and reference favipiravir products met the required bioequivalence criteria. Besides, both products were well tolerated and safe.
    MeSH term(s) Amides ; Antiviral Agents/therapeutic use ; Area Under Curve ; COVID-19/drug therapy ; Cross-Over Studies ; Healthy Volunteers ; Humans ; Male ; Pyrazines ; SARS-CoV-2 ; Tablets ; Therapeutic Equivalency
    Chemical Substances Amides ; Antiviral Agents ; Pyrazines ; Tablets ; favipiravir (EW5GL2X7E0)
    Language English
    Publishing date 2021-02-24
    Publishing country Germany
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 124384-6
    ISSN 0946-1965 ; 0340-0026 ; 0300-9718 ; 0174-4879
    ISSN 0946-1965 ; 0340-0026 ; 0300-9718 ; 0174-4879
    DOI 10.5414/CP203936
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Determination of albendazole sulfoxide in human plasma by using liquid chromatography-tandem mass spectrometry.

    Saraner, Nihal / Özkan, Güler Yağmur / Güney, Berrak / Alkan, Erkin / Burul-Bozkurt, Nihan / Sağlam, Onursal / Fikirdeşici, Ezgi / Yıldırım, Mevlüt

    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

    2016  Volume 1022, Page(s) 1–5

    Abstract: A rapid, simple and sensitive method was developed and validated using liquid chromatography-tandem mass spectrometry (LC-MS/MS) for determination of albendazole sulfoxide (ABZOX) in human plasma. The plasma samples were extracted by protein ... ...

    Abstract A rapid, simple and sensitive method was developed and validated using liquid chromatography-tandem mass spectrometry (LC-MS/MS) for determination of albendazole sulfoxide (ABZOX) in human plasma. The plasma samples were extracted by protein precipitation using albendazole sulfoxide-d3 as internal standard (IS). The chromatographic separation was performed on Waters Xbridge C18Column (100×4.6mm, 3.5μm) with a mobile phase consisting of ammonia solution, water and methanol at a flow rate of 0.70mL/min. ABZOX was detected and identified by mass spectrometry with electrospray ionization (ESI) in positive ion and multiple-reaction monitoring (MRM) mode. The method was linear in the range of 3-1500ng/mL for ABZOX. This method was successfully applied to the bioequivalence study in human plasma samples.
    MeSH term(s) Albendazole/analogs & derivatives ; Albendazole/blood ; Albendazole/chemistry ; Albendazole/pharmacokinetics ; Chromatography, Liquid/methods ; Humans ; Linear Models ; Reproducibility of Results ; Sensitivity and Specificity ; Tandem Mass Spectrometry/methods
    Chemical Substances Albendazole (F4216019LN) ; albendazole sulfoxide (J39B52TV34)
    Language English
    Publishing date 2016-06-01
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1180823-8
    ISSN 1873-376X ; 0378-4347 ; 1570-0232 ; 1387-2273
    ISSN (online) 1873-376X
    ISSN 0378-4347 ; 1570-0232 ; 1387-2273
    DOI 10.1016/j.jchromb.2016.03.024
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Determination of albendazole sulfoxide in human plasma by using liquid chromatography–tandem mass spectrometry

    Saraner, Nihal / Berrak Güney / Erkin Alkan / Ezgi Fikirdeşici / Güler Yağmur Özkan / Mevlüt Yıldırım / Nihan Burul-Bozkurt / Onursal Sağlam

    Journal of chromatography. 2016 June 01, v. 1022

    2016  

    Abstract: A rapid, simple and sensitive method was developed and validated using liquid chromatography–tandem mass spectrometry (LC–MS/MS) for determination of albendazole sulfoxide (ABZOX) in human plasma. The plasma samples were extracted by protein ... ...

    Abstract A rapid, simple and sensitive method was developed and validated using liquid chromatography–tandem mass spectrometry (LC–MS/MS) for determination of albendazole sulfoxide (ABZOX) in human plasma. The plasma samples were extracted by protein precipitation using albendazole sulfoxide-d3 as internal standard (IS). The chromatographic separation was performed on Waters Xbridge C18Column (100×4.6mm, 3.5μm) with a mobile phase consisting of ammonia solution, water and methanol at a flow rate of 0.70mL/min. ABZOX was detected and identified by mass spectrometry with electrospray ionization (ESI) in positive ion and multiple-reaction monitoring (MRM) mode. The method was linear in the range of 3–1500ng/mL for ABZOX. This method was successfully applied to the bioequivalence study in human plasma samples.
    Keywords albendazole ; ammonia ; electrospray ionization mass spectrometry ; humans ; liquid chromatography ; methanol ; monitoring ; pharmacokinetics ; tandem mass spectrometry
    Language English
    Dates of publication 2016-0601
    Size p. 1-5.
    Publishing place Elsevier B.V.
    Document type Article
    ISSN 1570-0232
    DOI 10.1016/j.jchromb.2016.03.024
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top